# A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

Study · id `cardio:ct-nct01609140` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01609140](<https://clinicaltrials.gov/study/NCT01609140>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01609140

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.

## Technical summary

Registry record NCT01609140. Randomized; double masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 248 participants (enrolled count; ClinicalTrials.gov record NCT01609140, source copy `cardio:ctgov-nct01609140-2016-11-02`, retrieved 2026-10-31)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01609140, source copy `cardio:ctgov-nct01609140-2016-11-02`, retrieved 2026-10-31)
- Primary completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01609140, source copy `cardio:ctgov-nct01609140-2016-11-02`, retrieved 2026-10-31)
- Completion: 2013-07 (actual) (ClinicalTrials.gov record NCT01609140, source copy `cardio:ctgov-nct01609140-2016-11-02`, retrieved 2026-10-31)
- Countries: United States; Canada; Czechia; Germany; Hungary; New Zealand; Norway; Slovakia; South Africa (ClinicalTrials.gov record NCT01609140, source copy `cardio:ctgov-nct01609140-2016-11-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01609140-2016-11-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
- Condition: Coronary Heart Disease
- Intervention (Drug): MPSK3169A
- Intervention (Drug): MPSK3169A
- Intervention (Drug): MPSK3169A
- Intervention (Drug): MPSK3169A
- Intervention (Drug): MPSK3169A
- Intervention (Drug): Placebo
- Lead sponsor: Genentech, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: Genentech, Inc. (`cardio:org-genentech-inc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study) (`cardio:pubmed-28343601`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ab9d8db4566959aaaf92d1d13a0cc60459c5cb1f8ea432e858e2d5e49a398667
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
